Adaptive radiotherapy for head and neck cancer: Pitfalls and possibilities from the radiation oncologist's point of view

Documents similaires

• Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re‐radiotherapy
  par: Florian Janke, et autres
  Publié: (2024)
• Tumor volume changes after stereotactic, hypofractionated and conventional radiotherapy in paragangliomas of head and neck
  par: Paweł J. Polanowski, et autres
  Publié: (2024)
• Increased head and neck cancer linked to cannabis use
  par: Mary Beth Nierengarten
  Publié: (2024)
• Neoadjuvant immunochemotherapy for nonsurgical HPV‐negative head and neck cancer
  par: Mary Beth Nierengarten
  Publié: (2025)
• Role of primary care in opioid prescribing for older head and neck cancer survivors
  par: Talya Salz, et autres
  Publié: (2024)